By Counterforce Health Team in Ocrevus (ocrelizumab) —

How to Get Ocrevus (Ocrelizumab) Covered by UnitedHealthcare in Florida: Complete Guide with Forms, Appeals, and Timelines

Answer Box: Getting Ocrevus Covered by UnitedHealthcare in Florida

Yes, UnitedHealthcare covers Ocrevus (ocrelizumab) for multiple sclerosis, but requires prior authorization with specific documentation. Your neurologist submits the PA request through the UHC Provider Portal or by fax to 866-940-7328, including MS diagnosis confirmation, hepatitis B screening results, and evidence of disease activity. Standard approval takes 15-30 business days. If denied, Florida law guarantees internal appeals within 30 days and external review through the state's independent process.

Start today: Contact your neurologist to initiate the prior authorization request and gather required documentation.

Table of Contents

  1. Coverage Basics
  2. Prior Authorization Process
  3. Required Documentation
  4. Timeline and Status Checks
  5. Costs and Copay Information
  6. Common Denial Reasons
  7. Appeals Process in Florida
  8. Annual Renewals
  9. Specialty Pharmacy Requirements
  10. Troubleshooting Common Issues
  11. FAQ

Coverage Basics

Is Ocrevus Covered by UnitedHealthcare?

UnitedHealthcare covers Ocrevus (ocrelizumab) as a Tier 5 specialty medication for treating relapsing forms of multiple sclerosis and primary progressive MS. However, coverage requires prior authorization through OptumRx, UnitedHealthcare's pharmacy benefit manager.

Which UnitedHealthcare Plans Cover Ocrevus?

  • Medicare Advantage plans: 29% coinsurance after deductible
  • Commercial/employer plans: Varies by specific plan design
  • Marketplace (ACA) plans: Subject to prior authorization requirements
Note: Medicare Advantage patients cannot use manufacturer copay assistance programs, but commercial plan members may be eligible for up to $20,000 annually through the Ocrevus Co-pay Program.

Prior Authorization Process

Step-by-Step: Fastest Path to Approval

  1. Schedule neurologist appointment (Patient action)
    • Gather insurance card and previous treatment records
    • Timeline: Same day you decide to pursue Ocrevus
  2. Neurologist completes PA form (Provider action)
  3. Submit via UHC Provider Portal (Provider action)
    • Primary method: UHCprovider.com
    • Alternative: Fax to 866-940-7328
    • Timeline: Same day as completion
  4. UnitedHealthcare reviews request (Insurer action)
    • Standard review: 15-30 business days
    • Expedited review: 72 hours if medically urgent
  5. Receive approval or denial (All parties)
    • Approval: Begin treatment coordination
    • Denial: Proceed to appeals process

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all Ocrevus prescriptions UHC Provider Portal UHC PA Requirements
MS Diagnosis Confirmed RRMS, PPMS, or active SPMS Neurologist records UHC Ocrevus Policy
Hepatitis B Screening Negative test results required Lab reports UHC PA Form
Disease Activity Relapse within 2 years OR active MRI Medical records/imaging UHC PA Form
Annual Renewal Required every 12 months Provider portal UHC Ocrevus Policy

Required Documentation

Essential Documents for PA Submission

Your neurologist must provide:

  • Completed prior authorization form (all pages)
  • Recent clinic note (within 90 days) documenting:
    • Specific MS phenotype (RRMS, PPMS, active SPMS)
    • Current EDSS score
    • Treatment response summary
    • Any adverse events or infections
  • Latest MRI report (within 12 months) showing active disease
  • Hepatitis B screening results (negative required)
  • Prior DMT documentation showing inadequate response to two or more FDA-approved therapies

Clinician Corner: Medical Necessity Letter Checklist

When writing supporting documentation, neurologists should include:

✓ Problem statement: Specific MS diagnosis with ICD-10 code
✓ Prior treatments: Names, doses, duration, and reasons for discontinuation
✓ Clinical rationale: Why Ocrevus is medically necessary
✓ Guideline support: Reference to FDA labeling or MS society guidelines
✓ Monitoring plan: How patient will be followed for safety and efficacy

Timeline and Status Checks

How Long Does Approval Take?

  • Standard review: 15-30 business days
  • Initial processing: 5-15 business days
  • Minimum review time: 24 hours (per UHC policy)

Checking Your Status

Providers can track PA status through:

  • UHC Provider Portal "Act on Claim" section
  • Phone: 866-889-8054 or 888-397-8129

Patients can check by:

  • Calling the number on their denial letter
  • Asking their neurologist's office for updates
Tip: Start renewal requests 4-6 weeks before current authorization expires to avoid treatment gaps.

Costs and Copay Information

What You'll Pay

Medicare Advantage plans: 29% coinsurance of negotiated price (potentially thousands per infusion)

Commercial plans: Varies by plan design, but eligible for manufacturer assistance

Saving Money on Ocrevus

For commercial insurance holders:

  • Ocrevus Co-pay Program: Up to $20,000/year assistance
  • Eligibility: Private/commercial insurance only (excludes Medicare, Medicaid)

For Medicare patients:

  • Medicare Part D Extra Help (if low-income qualified)
  • State pharmaceutical assistance programs
  • Patient foundation grants

Common Denial Reasons

Why UnitedHealthcare Denies Ocrevus

Denial Reason How to Overturn Required Documentation
No confirmed MS diagnosis Submit detailed neurology evaluation ICD-10 code, MRI reports, clinical assessment
Insufficient prior DMT trials Document failed therapies Pharmacy records, physician notes on intolerance/failure
Missing hepatitis B screening Provide negative test results Recent lab report (within 6 months)
Not medically necessary Submit medical necessity letter Physician rationale, current symptoms, treatment goals
Combination therapy concerns Clarify single-agent use Medication list, physician confirmation

When Counterforce Health Can Help

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to draft point-by-point rebuttals using the right medical evidence—FDA labeling, peer-reviewed studies, and specialty guidelines—aligned to your specific UnitedHealthcare plan's requirements.

Appeals Process in Florida

Internal Appeals (Required First Step)

Timeline to file: 180 days from denial notice
UHC decision deadline: 30 days (standard), 72 hours (expedited)
How to submit: UHC Provider Portal or address in denial letter

External Review (After Internal Denial)

Florida's independent review process:

  • Timeline to request: 4 months after final internal denial
  • How to request: Through Florida Department of Financial Services
  • Cost: Free to consumers
  • Decision timeline: 45-60 days typical
  • Binding: Yes, if approved

Appeals Playbook for UnitedHealthcare in Florida

  1. Gather evidence immediately after denial
  2. Submit reconsideration (informal first step) via provider portal
  3. File formal internal appeal if reconsideration denied
  4. Request external review through Florida DOI if internal appeal fails
  5. Contact Florida Insurance Consumer Helpline: 877-693-5236
From our advocates: "We've seen UnitedHealthcare approvals after initially denying Ocrevus when providers submitted comprehensive documentation showing failed traditional DMTs and clear evidence of active disease progression. The key was demonstrating medical necessity with specific clinical markers rather than general MS diagnosis alone."

Annual Renewals

When to Renew

UnitedHealthcare requires annual reauthorization for Ocrevus. Authorization periods are limited to 12 months maximum.

Renewal Requirements

For continuation therapy, provide:

  • Confirmation of previous Ocrevus treatment
  • Documentation of positive clinical response
  • Updated clinic note showing current status
  • Any new safety monitoring results

Timeline: Submit renewal requests 60-90 days before expiration to ensure continuous coverage.

Recent Policy Changes

As of May 1, 2025, OptumRx eliminated reauthorization requirements for select chronic disease medications, potentially including some MS treatments. However, initial prior authorization is still required for new Ocrevus prescriptions.

Specialty Pharmacy Requirements

Why Your Prescription Gets Transferred

UnitedHealthcare requires Ocrevus to be dispensed through specialty pharmacy networks due to:

  • Complex handling and storage requirements
  • Need for patient education and monitoring
  • Coordination with infusion centers
  • Insurance verification and prior authorization management

Working with Specialty Pharmacies

Your specialty pharmacy will:

  • Coordinate with your neurologist's office
  • Verify insurance coverage and copay assistance
  • Schedule delivery to infusion center
  • Provide patient education materials
  • Monitor for side effects and drug interactions

Troubleshooting Common Issues

Portal Problems

If the UHC Provider Portal is down:

  • Fax PA requests to 866-940-7328
  • Call 866-889-8054 for status updates
  • Keep confirmation receipts for all submissions

Missing Forms or Information

If UHC requests additional documentation:

  • Respond within the specified timeframe (usually 14 days)
  • Submit via the same method as original request
  • Include reference number from original submission

Communication Issues

If you're not receiving updates:

  • Verify contact information with UHC
  • Check spam/junk folders for emails
  • Ask your provider to check portal messages
  • Call member services number on insurance card

FAQ

Q: How long does UnitedHealthcare prior authorization take for Ocrevus in Florida?
A: Standard review takes 15-30 business days. Expedited review (for urgent medical situations) takes up to 72 hours.

Q: What if Ocrevus is not on my UnitedHealthcare formulary?
A: Ocrevus is typically covered as a Tier 5 specialty medication, but you may need to pay higher coinsurance. Your doctor can request a formulary exception with medical justification.

Q: Can I request an expedited appeal in Florida?
A: Yes, if delay in treatment would jeopardize your life, health, or ability to function. Both UnitedHealthcare and Florida's external review process offer expedited timelines.

Q: Does step therapy apply if I've tried other DMTs outside Florida?
A: Yes, UnitedHealthcare accepts prior therapy documentation from any state. Ensure your neurologist includes complete treatment history in the PA request.

Q: What happens if I miss my renewal deadline?
A: Your coverage may lapse, requiring a new prior authorization. Contact your neurologist immediately to submit an expedited renewal request.

Q: Can I appeal a denial myself, or does my doctor need to do it?
A: Both patients and providers can file appeals. However, provider appeals often carry more weight because they can include detailed clinical documentation.

Q: How often do UnitedHealthcare Ocrevus appeals succeed?
A: Approximately 17% of UnitedHealthcare denials are overturned on appeal, with higher success rates when comprehensive clinical documentation supports medical necessity.

Q: What should I do if UnitedHealthcare approves Ocrevus but my specialty pharmacy can't fill it?
A: Contact UHC member services to verify which specialty pharmacies are in-network for Ocrevus. You may need to switch to an approved specialty pharmacy provider.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage varies by individual plan. Always consult with your healthcare provider and insurance company for personalized guidance.

For additional help with insurance issues in Florida, contact the Florida Department of Financial Services Insurance Consumer Helpline at 877-693-5236.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.